Claim Missing Document
Check
Articles

Found 34 Documents
Search

Efficacy and Safety of Tenofovir in Preventing Perinatal Hepatitis B in Jakarta Muzakar, Cholid; Sandhiutami, Ni Made Dwi; Ramadaniati, Hesty Utami; Sriyono, Bimantoko Hadi
Sciences of Pharmacy Volume 5 Issue 1
Publisher : ETFLIN

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0501485

Abstract

Vertical transmission of hepatitis B virus (HBV) remains a major public health challenge in Indonesia, particularly among pregnant women with high viral loads. Tenofovir disoproxil fumarate (TDF) has been recommended to prevent perinatal transmission; however, local data regarding its efficacy and safety remain limited. This study aimed to evaluate Analyzing the effectiveness and safety of TDF in HBsAg-reactive pregnant women and its relationship with the infant's HBsAg status is necessary. An observational cohort study was conducted on 103 HBsAg-reactive pregnant women at five referral health facilities in Jakarta. Maternal effectiveness was measured by changes in SGPT and SGOT levels before and after therapy using the Wilcoxon test. Safety was assessed based on adverse events, pregnancy complications, and renal function using the chi-square test. Infant effectiveness was analyzed based on HBsAg status and tested using multivariate logistic regression. TDF significantly reduced SGPT and SGOT levels (p < 0.001). No significant association was found between TDF duration and adverse events, complications, or renal impairment (p > 0.05). Ninety-one-three percent of infants were HBsAg non-reactive, and 93.2% received complete hepatitis B vaccination. Complete vaccination (OR = 414.52; p < 0.001) and the absence of pregnancy complications (OR = 0.048; p = 0.021) were the main protective factors. TDF is safe and effective in preventing vertical transmission of HBV. Successful prophylaxis is highly dependent on infant vaccination and maternal health. These results support the integration of TDF into the national hepatitis B elimination program. 
Animal Models of Acute Exacerbations COPD: Mechanistic Insights and Translational Challenges Dewi, Rika Sari; Wuyung, Puspita Eka; Louisa, Melva; Sandhiutami, Ni Made Dwi; Pratomo, Irandi Putra
Sciences of Pharmacy Volume 5 Issue 1
Publisher : ETFLIN

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0501482

Abstract

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) represent critical events in disease progression, yet their complex pathophysiology remains incompletely understood. Understanding the mechanisms underlying these exacerbations is essential for developing effective therapeutic strategies and improving patient outcomes. This literature review aims to synthesize current knowledge on the cellular and molecular mechanisms driving acute exacerbations of COPD, highlighting the importance of utilizing appropriate animal models for future research. This review identified rodent models, particularly mice (C57BL/6 strain) and rats (Sprague-Dawley) are predominantly employed due to their genetic tractability and physiological relevance, with occasional use of guinea pigs for airway hyperresponsiveness studies. Combined approaches using cigarette smoke exposure followed by inflammatory triggers (LPS, viral infections) showed the highest translational relevance. Key pathophysiological mechanisms studied include neutrophilic inflammation, oxidative stress, airway remodelling, and mucus hypersecretion. Current animal models provide valuable insight into AECOPD pathophysiology but face limitations in fully recapitulating human disease complexity. Future directions should focus on incorporating comorbidities, aging, and standardized outcome measures.
Analysis of the Rationality of Antibiotic Use in Pediatric Bronchopneumonia Patients and its Impact on Clinical Outcomes and Costs at RS Columbia Asia Pulomas Jakarta Period April 2024–April 2025 Yuwono, Wahyu Agung; Khairani, Sondang; Lizikri, Assajadda; Sandhiutami, Ni Made Dwi
Enrichment: Journal of Multidisciplinary Research and Development Vol. 3 No. 11 (2026): Enrichment: Journal of Multidisciplinary Research and Development
Publisher : International Journal Labs

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55324/enrichment.v3i11.612

Abstract

Bronchopneumonia is one of the leading causes of morbidity and mortality in the pediatric population, especially in developing countries such as Indonesia. This condition also imposes a considerable economic burden due to the long duration of treatment and the frequent use of antibiotics, which are often inappropriate. This study aimed to evaluate the rationality of antibiotic administration in pediatric patients hospitalized with a diagnosis of bronchopneumonia at Columbia Asia Pulomas Hospital Jakarta during the period from April 2024 to April 2025, and to analyze its effect on clinical outcomes and treatment costs. This study used a retrospective cross-sectional design with a total sampling approach of 164 patients through a review of medical records and cost data. The rationality of antibiotic therapy was assessed using the Gyssens method, and the relationship between variables was analyzed using bivariate statistical tests. The study found that 71.9% of rational antibiotic use correlated with a higher clinical improvement rate of 80.5% compared to 52.2% for irrational antibiotic use (p = 0.000). However, there was no significant difference in the duration of hospitalization between rational antibiotic use (4.70 ± 0.82 days) and irrational antibiotic use (5.41 ± 2.25 days) (p = 0.612), nor in the total cost of hospitalization (rational use: Rp 15,956,032.66 ± Rp 5,568,892.10 vs. irrational use: Rp 18,801,283.94 ± Rp 11,292,810.87) (p = 0.658). These results emphasize the importance of antibiotic rationality analysis as an effort to improve clinical outcomes without having a significant impact on cost efficiency or treatment duration.
INCREASING ANTIOXIDANT ACTIVITY OF SUPEROXIDE DISMUTASE AND DECREASING MALONDIALDEHYD LEVELS FROM Ethanol Extract of Radish (Raphanus Sativus L.) LEAVES IN SWIMMING MICE Khairani, Sondang; Sandhiutami, Ni Made Dwi; Sari, Ika Permata
Farmasains : Jurnal Ilmiah Ilmu Kefarmasian Vol. 10 No. 1 (2023)
Publisher : Universitas Muhammadiyah Prof. DR. HAMKA

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22236/farmasains.v10i1.8261

Abstract

Daun lobak (Raphanus sativus L.) mengandung senyawa flavonoid yang memiliki aktivitas sebagai antioksidan. Penelitian ini bertujuan untuk menguji efek antioksidan ekstrak etanol 70% daun lobak (Raphanus sativus L.) berdasarkan parameter kadar malondialdehid (MDA) dan aktivitas superoksida dismutase (SOD). Penelitian menggunakan mencit dibagi menjadi 6 kelompok yaitu: kelompok kontrol normal (I), kelompok kontrol negative (II), kelompok kontrol positif (III) (vitamin C 2,6 mg/20 gBB), dan 3 kelompok (IV,V,VI)dosis ekstrak etanol 70% daun lobak (Raphanus sativus L.) (5,6; 11,2; 22,4 mg/20 gBB). Pengukuran kadar MDA dilakukan dengan metode Wills dan pengukuran aktivitas SOD dilakukan dengan metode Adrenochrome Assay dan Analisa menggunakan uji ANOVA. Hasil pengukuran kadar MDA pada kelompok normal, kelompok kontrol negatif, kelompok kontrol negatif, kelompok kontrol positif, kelompok dosis 5,6 mg/20 gBB; 11,2 mg/20 gBB; 22,4 mg/20 gBB secara berturut-turut adalah 2,1617 nmol/mL; 5,3075 nmol/mL; 2,3331 nmol/mL; 4,5583 nmol/mL; 3,5957 nmol/mL; 2,6702 nmol/mL sedangkan untuk hasil pengukuran aktivitas SOD hati mencit adalah 124,2383 U/mL; 65,64 U/mL; 176,7583 U/mL; 106,045 U/mL; 134,34 U/mL; 153,53 U/mL. Kesimpulan penelitian ini adalah terdapat perbedaan bermakna antara kelompok III dengan kelompok IV,V,VI  dalam peningkatan aktivitas SOD dan penurunan kadar MDA (p<0,05) yaitu memiliki potensi antioksidan yang sama seperti vitamin C.